Dupixent approved in the US as the first-ever biologic medicine for patients with COPD Dupixent is indicated for the approximately 300,000 adults in the US with inadequately ...
The Point-of-Care Diagnostics market is driven by the increasing demand for rapid and accurate testing solutions, particularly in remote and resource-limited settings. Technological advancements, such ...